Randomized Clinical Trial
Copyright ©The Author(s) 2016.
World J Hepatol. May 18, 2016; 8(14): 625-631
Published online May 18, 2016. doi: 10.4254/wjh.v8.i14.625
Figure 1
Figure 1 Flow diagram of study patients. PEG-IFN: Pegylated interferon; ETR: End of treatment response.
Figure 2
Figure 2 Number of patients who became hepatitis D virus RNA negative. HDV: Hepatitis D virus; PEG-IFN: Pegylated interferon.